Allianz Group highlights global presence and financial results for fiscal year 2024

Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) Allianz SE
Oliver Bäte Chairman of the Board of Management of Allianz SE (CEO) - Allianz SE
0Comments

The Allianz Group operates in nearly 70 countries, providing insurance and asset management services to private and corporate clients. Its offerings include property, life, health, assistance, credit, and global business insurance. The company manages approximately 768 billion euros for its insurance customers and about 1.9 trillion euros in third-party assets through PIMCO and Allianz Global Investors. In 2024, the group reported a total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros with over 156,000 employees.

Allianz emphasizes the integration of ecological and social criteria into its business processes and investment decisions. According to the company, this approach has positioned it among industry leaders in the Dow Jones Sustainability Index.

“Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance.”

“Allianz is one of the world’s largest investors, managing around 768 billion euros** on behalf of its insurance customers.”

“Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.9 trillion euros** of third-party assets.”

“Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index.”

“In 2024, over 156,000 employees achieved total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros for the group.”

** As of March 31, 2025.

For more information about Allianz’s recent performance figures: https://www.allianz.com/en/investor_relations/results-reports/financial-results.html



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.